Phosphorylation of Akt/GSK-3β/eNOS amplifies 5-HT2Breceptor blockade mediated anti-hypertrophic effect in rats

Telmisartan, a dual ARB/partial PPAR-γ agonist, protects myocardium from ischaemic reperfusion injury in experimental diabetes

(2011) S. N. Goyal et al.   DIABETES OBESITY & METABOLISM

Role of 5-HT2B receptors in cardiomyocyte apoptosis in noradrenaline-induced cardiomyopathy in rats

(2010) Chong-Feng Bai et al.   CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY

NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart

(2010) J. Kuroda et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Role of Glycogen Synthase Kinase-3β in Cardioprotection

(2009) Magdalena Juhaszova et al.   CIRCULATION RESEARCH

Akt regulates L-type Ca2+channel activity by modulating Cavα1 protein stability

(2009) Daniele Catalucci et al.   JOURNAL OF CELL BIOLOGY

Apoptotic and non-apoptotic programmed cardiomyocyte death in ventricular remodelling

(2008) G. W. Dorn   CARDIOVASCULAR RESEARCH

Overcoming an Energy Crisis?

(2008) Peiyong Zhai et al.   CIRCULATION RESEARCH

Serotonin 5-HT 2B Receptor Blockade Prevents Reactive Oxygen Species–Induced Cardiac Hypertrophy in Mice

(2008) Laurent Monassier et al.   HYPERTENSION

Cardioprotective Effect of Morphine and a Blocker of Glycogen Synthase Kinase 3 , SB216763 [3-(2,4-Dichlorophenyl)-4(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione], via Inhibition of the Mitochondrial Permeability Transition Pore

(2008) F. N. Obame et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

5-Hydroxytryptamine and cardiovascular regulation

(2008) A RAMAGE et al.   TRENDS IN PHARMACOLOGICAL SCIENCES